617 related articles for article (PubMed ID: 33729394)
21. An ncRNA transcriptomics-based approach to design siRNA molecules against SARS-CoV-2 double membrane vesicle formation and accessory genes.
Nawaz R; Arif MA; Ahmad Z; Ahad A; Shahid M; Hassan Z; Husnain A; Aslam A; Raza MS; Mehmood U; Idrees M
BMC Infect Dis; 2023 Dec; 23(1):872. PubMed ID: 38087193
[TBL] [Abstract][Full Text] [Related]
22. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.
Obajuluwa AO; Okiki PA; Obajuluwa TM; Afolabi OB
Pan Afr Med J; 2020; 37():285. PubMed ID: 33654512
[TBL] [Abstract][Full Text] [Related]
23. Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs.
Thura M; Sng JXE; Ang KH; Li J; Gupta A; Hong JM; Hong CW; Zeng Q
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34519332
[TBL] [Abstract][Full Text] [Related]
24. Accessory proteins of SARS-CoV and other coronaviruses.
Liu DX; Fung TS; Chong KK; Shukla A; Hilgenfeld R
Antiviral Res; 2014 Sep; 109():97-109. PubMed ID: 24995382
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
26. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
27. Protein post-translational modification in SARS-CoV-2 and host interaction.
Cheng N; Liu M; Li W; Sun B; Liu D; Wang G; Shi J; Li L
Front Immunol; 2022; 13():1068449. PubMed ID: 36713387
[TBL] [Abstract][Full Text] [Related]
28. Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity.
Case JB; Li Y; Elliott R; Lu X; Graepel KW; Sexton NR; Smith EC; Weiss SR; Denison MR
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046453
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing antibodies mediate virus-immune pathology of COVID-19.
Jacobs JJL
Med Hypotheses; 2020 Oct; 143():109884. PubMed ID: 32512289
[TBL] [Abstract][Full Text] [Related]
31. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2
Lehrer S; Rheinstein PH
In Vivo; 2020 Jun; 34(3 Suppl):1629-1632. PubMed ID: 32503821
[TBL] [Abstract][Full Text] [Related]
33. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.
Achom A; Das R; Pakray P
Comput Biol Med; 2022 Dec; 151(Pt A):106050. PubMed ID: 36334362
[TBL] [Abstract][Full Text] [Related]
34. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
Mol Biol Evol; 2021 May; 38(6):2428-2445. PubMed ID: 33555346
[TBL] [Abstract][Full Text] [Related]
35. Basic virology of SARS-CoV 2.
Ravi V; Saxena S; Panda PS
Indian J Med Microbiol; 2022; 40(2):182-186. PubMed ID: 35300895
[TBL] [Abstract][Full Text] [Related]
36. A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells.
Basu A; Penumutchu S; Nguyen K; Mbonye U; Tolbert BS; Karn J; Komar AA; Mazumder B
J Virol; 2022 Jan; 96(2):e0167821. PubMed ID: 34757848
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis.
McGrath ME; Xue Y; Dillen C; Oldfield L; Assad-Garcia N; Zaveri J; Singh N; Baracco L; Taylor LJ; Vashee S; Frieman MB
Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2204717119. PubMed ID: 36040867
[TBL] [Abstract][Full Text] [Related]
38. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses.
Kirtipal N; Bharadwaj S; Kang SG
Infect Genet Evol; 2020 Nov; 85():104502. PubMed ID: 32798769
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
40. Host cell-intrinsic innate immune recognition of SARS-CoV-2.
Madden EA; Diamond MS
Curr Opin Virol; 2022 Feb; 52():30-38. PubMed ID: 34814102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
